Home Topics Mapp Biopharmaceuticals

Mapp Biopharmaceuticals

Four new cases of Ebola confirmed In Congo

Four new cases of Ebola virus have been confirmed in the eastern Democratic Republic of Congo, the health ministry said, as authorities prepare to deploy an experimental treatment.

Recent Stories

EU ‘no-deal’ Brexit plan has bad news for travellers

The EU published contingency plans for a “no-deal” Brexit on Tuesday, outlining a host of travel rights Britons would lose, from recognition of driving licences to loss of pet passports.

INEC: 13,000 PVCs unclaimed in Kuje

The Independent National Electoral Commission (INEC), says no fewer than 13,000 registered voters were yet to collect their Permanent Voters Cards (PVCs) in Kuje Area Council of the FCT.
Kola Ologbondiyan

Kwara bye-election: PDP warns against use of security to intimidate voters

The Peoples Democratic Party (PDP) has cautioned against “plot’’ to use the police as a tool to intimidate voters and rig the Irepodun/Ekiti/Oke-Ero/Isin Federal Constituency by-election in Kwara scheduled for Saturday.
Second Niger Bridge

Federal government awards N206 billion contract for 2nd Niger Bridge to Julius Berger

The federal government has awarded Julius Berger Construction Company a N206 billion contract for the main work on the 2nd Niger Bridge.

Rob Shuter: MTN to acquire banking licence in Nigeria

Rob Shuter, the chief executive officer at MTN Group, says the group will acquire an independent banking licence in Nigeria by 2019.